1. Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
   Ryan D. Salinas et al, 2020, CNS Drugs CrossRef
2. The Third Generation Anti-HER2 Chimeric Antigen Receptor Mouse T Cells Alone or Together With Anti-PD1 Antibody Inhibits the Growth of Mouse Breast Tumor Cells Expressing HER2 in vitro and in Immune Competent Mice
   Panyuan Li et al, 2020, Front. Oncol. CrossRef
3. CAR-T in solid tumors: Blazing a new trail through the brambles
   Feifei Guo et al, 2020, Life Sciences CrossRef
4. Glioblastoma Immune Landscape and the Potential of New Immunotherapies
   Thomas Daubon et al, 2020, Front. Immunol. CrossRef
5. Nanoparticle-Loaded Polarized-Macrophages for Enhanced Tumor Targeting and Cell-Chemotherapy
   Teng Hou et al, 2021, Nano-Micro Lett. CrossRef
6. CAR T Cell-Based Immunotherapy for the Treatment of Glioblastoma
   Luke Maggs et al, 2021, Front. Neurosci. CrossRef
7. Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
   Nicholas A. Vitanza et al, 2021, Nat Med CrossRef
8. New Immunotherapeutic Approaches for Glioblastoma
   Gustavo Ignacio Vázquez Cervantes et al, 2021, Journal of Immunology Research CrossRef
9. Bone Metastases of Glioblastoma: A Case Report and Review of the Literature
   Wei Zhang et al, 2021, Front. Oncol. CrossRef
10. Improving CAR T-Cell Persistence
    Violena Pietrobon et al, 2021, IJMS CrossRef
11. Cell-Based Therapy for the Treatment of Glioblastoma: An Update from Preclinical to Clinical Studies
    Noha Attia et al, 2021, Cells CrossRef
12. CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future
    Ya-Jui Lin et al, 2022, Front. Immunol. CrossRef
13. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies
    Laura Antonucci et al, 2022, Front. Immunol. CrossRef
14. Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
    Alaa Alnefaie et al, 2022, Front. Bioeng. Biotechnol. CrossRef
15. CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
    Manasi P. Jogalekar et al, 2022, Front. Immunol. CrossRef
16. Combating challenges in CAR-T cells with engineering immunology
    Clement Yisai Wang et al, 2022, Front. Cell Dev. Biol. CrossRef
17. null
    Athina Malliou et al, 2022 CrossRef
18. Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma
    Saïf Eddine Zaidi et al, 2023, BioDrugs CrossRef
19. FDA-Approved Chimeric Antigen Receptor (CAR)-T Cell Therapy for Different Cancers-A Recent Perspective
    R. Thirumalaisamy et al, 2024, Mol Biotechnol CrossRef